Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature JJ Fütterer, A Briganti, P De Visschere, M Emberton, G Giannarini, ... European urology 68 (6), 1045-1053, 2015 | 918 | 2015 |
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 192 | 2020 |
A systematic review on the role of imaging in early recurrent prostate cancer PJL De Visschere, C Standaert, JJ Fütterer, GM Villeirs, V Panebianco, ... European urology oncology 2 (1), 47-76, 2019 | 178 | 2019 |
Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 … GM Villeirs, GO De Meerleer, PJ De Visschere, VH Fonteyne, ... European journal of radiology 77 (2), 340-345, 2011 | 144 | 2011 |
Salvage lymph node dissection for nodal recurrent prostate cancer: a systematic review G Ploussard, G Gandaglia, H Borgmann, P De Visschere, I Heidegger, ... European urology 76 (4), 493-504, 2019 | 133 | 2019 |
Multidisciplinary approach to prostatitis V Magri, M Boltri, T Cai, R Colombo, S Cuzzocrea, P De Visschere, ... Archivio Italiano di Urologia e Andrologia 90 (4), 227-248, 2018 | 133 | 2018 |
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma N Sundahl, G Vandekerkhove, K Decaestecker, A Meireson, ... European urology 75 (5), 707-711, 2019 | 112 | 2019 |
Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant … P De Visschere, N Lumen, P Ost, K Decaestecker, E Pattyn, G Villeirs Clinical radiology 72 (1), 23-32, 2017 | 100 | 2017 |
Role of MRI in follow-up after focal therapy for prostate carcinoma PJ De Visschere, GO De Meerleer, JJ Futterer, GM Villeirs American Journal of Roentgenology 194 (6), 1427-1433, 2010 | 97 | 2010 |
What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging? PJL De Visschere, L Naesens, L Libbrecht, C Van Praet, N Lumen, ... European radiology 26, 1098-1107, 2016 | 94 | 2016 |
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU … A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... Annals of Oncology 30 (11), 1697-1727, 2019 | 90 | 2019 |
External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection G Gandaglia, A Martini, G Ploussard, N Fossati, A Stabile, P De Visschere, ... European urology 78 (2), 138-142, 2020 | 89 | 2020 |
Clinical and imaging tools in the early diagnosis of prostate cancer, a review P De Visschere, W Oosterlinck, G De Meerleer, G Villeirs Journal of the Belgian Society of Radiology 93 (2), 62-70, 2010 | 74 | 2010 |
Detection of clinically significant prostate cancer: short dual–pulse sequence versus standard multiparametric MR imaging—a multireader study BK Barth, PJL De Visschere, A Cornelius, C Nicolau, HA Vargas, D Eberli, ... Radiology 284 (3), 725-736, 2017 | 73 | 2017 |
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer PJL De Visschere, A Briganti, JJ Fütterer, P Ghadjar, H Isbarn, C Massard, ... Insights into imaging 7, 205-214, 2016 | 70 | 2016 |
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate PJL De Visschere, A Vral, G Perletti, E Pattyn, M Praet, V Magri, ... European radiology 27, 2095-2109, 2017 | 62 | 2017 |
Nodal oligorecurrent prostate cancer: anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates A De Bruycker, E De Bleser, K Decaestecker, V Fonteyne, N Lumen, ... European Urology 75 (5), 826-833, 2019 | 61 | 2019 |
Post-treatment complications of soft tissue tumours LG Shapeero, PJL De Visschere, KL Verstraete, B Poffyn, R Forsyth, ... European journal of radiology 69 (2), 209-221, 2009 | 55 | 2009 |
Population screening for prostate cancer: an overview of available studies and meta‐analysis N Lumen, V Fonteyne, G De Meerleert, P Ost, G Villeirs, A Mottrie, ... International journal of urology 19 (2), 100-108, 2012 | 52 | 2012 |
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies? G Ploussard, H Borgmann, A Briganti, P De Visschere, JJ Fütterer, ... World journal of urology 37, 243-251, 2019 | 51 | 2019 |